Alivus Life Sciences Ltd.

With no major difference for the quarter endedDecember 2025 , the total revenue stood at Rs. 6728.89  millions.The Company has registered profit of Rs. 1502.61  millions for the quarter ended December 2025, a growth of 9.71%  over Rs. 1369.60 millions millions achieved in the corresponding quarter of last year.Operating profit surged to 2452.01 millions from the corresponding previous quarter of 2007.64 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202512	202412	% Var	202512	202412	% Var	202503	202403	% Var
Sales	6728.89	6418.44	4.84	18627.15	17373.39	7.22	23868.84	22832.14	4.54
Other Income	139.28	104.56	33.21	376.33	244.82	53.72	345.70	120.42	187.08
PBIDT	2452.01	2007.64	22.13	6203.87	5086.34	21.97	7171.54	6862.88	4.50
Interest	14.94	4.58	226.20	40.63	11.54	252.08	24.14	15.46	56.14
PBDT	2180.50	2003.06	8.86	5906.67	5074.80	16.39	7147.40	6847.42	4.38
Depreciation	196.58	151.59	29.68	551.57	446.39	23.56	606.09	534.52	13.39
PBT	1983.92	1851.47	7.15	5355.10	4628.41	15.70	6541.31	6312.90	3.62
TAX	481.31	481.87	-0.12	1336.88	1190.82	12.27	1685.04	1604.02	5.05
Deferred Tax	-57.85	13.81	-518.90	8.85	45.19	-80.42	60.64	81.88	-25.94
PAT	1502.61	1369.60	9.71	4018.22	3437.59	16.89	4856.27	4708.88	3.13
Equity	245.36	245.07	0.12	245.36	245.07	0.12	245.07	245.05	0.01
PBIDTM(%)	36.44	31.28	16.50	33.31	29.28	13.76	30.05	30.06	-0.04